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Effectiveness of see-and-treat 
for approaching pre-invasive 
lesions of uterine cervix
Efetividade da abordagem “ver e 
tratar” em lesões pré-invasivas no 
colo uterino
ABSTRACT
OBJECTIVE: To compare the effectiveness between the see-and-treat 
(S&T) approach and the conventional one (with prior biopsy) for squamous 
intraepithelial lesions of uterine cervix.
METhODS: A cross-sectional study was conducted with 900 nonpregnant 
women with cytology suggestive of high grade squamous intraepithelial lesions 
in the city of Rio de Janeiro, Southeastern Brazil, between 1998 and 2004. The 
S&T approach consists of a large loop excision of the transformation zone 
procedure and is recommended when cytology is suggestive of high grade 
squamous intraepithelial lesion, satisfactory colposcopy with abnormalities 
compatible with the suspected cytological results, and the lesion is limited to 
the ectocervix or extends up to one centimeter of the endocervical canal. A 
subgroup of 336 patients whose colposcopy was considered satisfactory was 
analyzed, and they were divided into two groups for comparison: patients 
treated without prior biopsy (n = 288) and patients treated after a biopsy 
showing high grade squamous intraepithelial lesions (n = 48). Patients who 
were not treated or only treated more than a year later after recruitment at the 
colposcopy unit were considered dropouts.
RESULTS: Of patients recruited during the study period, 71 were not treated or 
were only treated for at least a year. The overall dropout rate was 7.9% (95% 
CI: 6.1;9.7). Mean time elapsed between patient recruitment and treatment was 
17.5 days in the S&T group and 102.5 days in the prior biopsy group. Dropout 
rates were 1.4% (95% CI: 0.04;2.7) and 5.% (95% CI: 0;12.3), respectively 
(p=0.07). The proportion of overtreated cases (negative histology) in the S&T 
group was 2.0% (95% CI: 0.4;3.6). 
CONCLUSIONS: The difference in the mean time elapsed between patient 
recruitment and treatment indicates that S&T is a time-saving approach The 
proportion of negative cases from using the S&T approach can be regarded 
as low.
DESCRIPTORS: Cervix Uteri, pathology. Colposcopy, classification. 
Cervical Intraepithelial Neoplasia. Uterine Cervical Neoplasms, 
diagnosis.
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The “see-and-treat” (S&T) approach for high-grade 
intraepithelial squamous lesions (HSIL) of uterine 
cervix consists of performing both diagnosis and 
treatment in one single visit. In Brazil, this approach 
was launched in 1997 as part of the National Programa 
for Uterine Cancer Management, Viva Mulher, to 
treat pre-invasive cervical lesions. The S&T approach 
included a large loop excision of the transformation 
zone (LLETZ)9  procedure and is recommended when 
cytology is suggestive of HSIL (or cervical intraepi-
thelial neoplasia grades 2 or 3 - CIN 2/3), satisfactory 
colposcopy (transformation zone completely visible) 
with abnormalities compatible with the suspected cyto-
logical results, and the lesion is limited to the ectocervix 
or extends up to one centimeter of the endocervical 
RESUMO
OBJETIVO: Comparar a efetividade do método “ver-e-tratar” (V&T) com a 
abordagem tradicional (biópsia prévia) das lesões escamosas intraepiteliais 
do colo uterino.
MéTODOS: Trata-se de um estudo transversal realizado na cidade do Rio de 
Janeiro, RJ, de 1998 a 2004, com 900 pacientes não gestantes que apresentavam 
citologia sugestiva de lesão intraepitelial escamosa de alto grau. O método 
V&T inclui a excisão ampla da zona de transformaçao que é indicada quando 
a citologia é sugestiva de lesão intra-epitelial escamosa de alto grau, a 
colposcopia é satisfatória e compatível com a alteração citológica e a alteração 
colposcópica deve estar limitada à ectocérvice e ao primeiro centímetro do 
canal cervical. Foi analisado o  subgrupo de 336  pacientes com colposcopias 
consideradas satisfatórias, compreendendo dois grupos para comparação: 
pacientes tratadas sem biópsia prévia (n=288) versus pacientes tratadas após 
a biópsia mostrando lesão intraepitelial escamosa de alto grau (n=48).  Foram 
consideradas perdas as pacientes não tratadas ou tratadas apenas um ano ou 
mais após recrutamento pela clínica de colposcopia, no grupo V&T.
RESULTADOS: Das pacientes recrutadas durante o período do estudo, 71 não 
foram tratadas ou foram tratadas apenas um ano mais tarde, fornecendo uma 
taxa global de abandonos de 7,9% (IC 95%: 6,1;9,7). O tempo médio entre a 
captação da paciente e o tratamento foi de 17,5 dias no V&T e 102,5 dias no 
grupo biópsia prévia. As taxas de perdas foram de 1,4% (IC 95%: 0,04;2,7) 
no grupo V&T e de 5,9% (IC 95%: 0;12,3) no de biópsia prévia (p=0,07). A 
proporção de tratamentos desnecessários (histologia negativa) no grupo V&T 
foi 2,0% (IC 95%: 0,4;3,6).
CONCLUSõES: A diferença de tempo médio entre a captação da paciente e 
o tratamento indicou que o V&T é um método que poupa tempo. A proporção 
de casos negativos quando o método V&T foi utilizado pode ser considerada 
baixa.
DESCRITORES: Colo do Útero, patologia. Colposcopia, classificação. 
Neoplasia Intra-Epitelial Cervical. Neoplasias do Colo do Útero, 
diagnóstico.
INTRODUCTION
a Sociedade Brasileira de Patologia do Trato Genital Inferior e Colposcopia. Rio de Janeiro. Manual de Cirurgia de Alta Frequência. 1998. 
canal. The main objective of the S&T approach is 
to reduce the odds of losing patients with precursor 
lesions after cytological screening. However, one of 
its disadvantages is potential unnecessary treatments 
as claimed by other authors.1,2,3, 5,11
The traditional approach with a targeted biopsy for 
diagnostic confirmation requires more medical visits 
before the actual treatment of the lesions.11  This causes 
increased anxiety to patients, which can in turn lead to 
dropout before treatment.2 It also increases care cost 
(in cases where treatment is required).
The S&T approach has been used at the Colposcopy 
Unit of the Department of Gynecology at Instituto 
Fernandes Figueira, Fundação Oswaldo Cruz (IFF/
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a Conjugated estrogens, 0.625 mg (oral) seven to ten days prior to the next colposcopic examination. 
FIOCRUZ), since 1998 following the guidelines of 
the National Program for Uterine Cancer Management. 
The traditional approach is used when S&T criteria 
are not met.
The objective of the present study was to compare the 
effectiveness of S&T to the conventional approach 
(with prior biopsy) in squamous intraepithelial lesions 
of uterine cervix.
METhODS
From October 1998 to December 2004, 900 nonpreg-
nant patients with cytology suggestive of HSIL through 
the screening program for cervical cancer and precursor 
lesions were recruited in the city of Rio de Janeiro, 
southeastern Brazil, as well as through informal refer-
rals from primary health care units. We tabulated the 
number of patients who ended up not being treated or 
were only treated for up to a year after recruitment.
We retrospectively analyzed the subgroup of 336 
patients whose colposcopy was considered satisfactory, 
and they were divided into two groups for comparison: 
(1) S&T group – patients submitted to LLETZ proce-
dure without prior biopsy, and having met the study 
criteria, and (2) prior biopsy group – patients submitted 
to LLETZ after prior biopsy showing HSIL (Figure).
LLETZ was performed under local anesthesia as an 
outpatient procedure. When colposcopic abnormali-
ties were incompatible with the cytological results, 
a biopsy was performed for subsequent treatment if 
HSIL was confirmed (conventional approach). In this 
case, the biopsy was also performed under local anes-
thesia. When the squamocolumnar junction (SCJ) was 
not visible or the transformation zone (TZ) extended 
beyond one centimeter into the canal, the patient was 
referred for conization in the operating room, and 
excluded from the study.
Some patients in the S&T group were not submitted to 
this approach on the same day either because they were 
menstruating, had colpitis, or SCJ was not totally visible 
in the first visit. These patients were then scheduled 
for another visit after their menstrual period or after 
either treatment of colpitis or estrogen preparation.a 
They remained in their original group as they had not 
undergone biopsy prior to the treatment. This may 
also explain the mean time elapsed between patient 
recruitment at the unit and treatment implementation is 
greater than zero. Other patients were not submitted to 
this approach due to logistic problems (lack of equip-
ment or supervisory staff, patient preference) and went 
through the prior biopsy approach.
We estimated the mean time elapsed between patient 
capture at the colposcopy unit and treatment in 
those submitted to LLETZ, excluding those patients 
who were already recruited with biopsy consistent 
with HSIL performed before being referred to IFF/
FIOCRUZ. We then compared the two approaches for 
the rate of dropouts without treatment among patients 
with satisfactory colposcopy. We considered dropouts 
in the S&T group when patients had major colposcopic 
alterations but were not treated or were only treated 
more than a year later. In the prior biopsy group, we 
considered those patients who had a biopsy showing 
HSIL but were not treated or were treated only more 
than a year later.
We also verified the histological diagnoses in those 
patients submitted to LLETZ in the S&T approach to 
evaluate the proportion of overtreated cases.
The study data were analyzed using SPSS (version 8.0). 
To test the difference between means, Student’s t-test 
was used, and to test the difference between proportions 
of dropouts Fisher’s exact test was used. A 5% level of 
significance was set.
RESULTS
The Figure shows the study population and its 
subgroups. Of 900 nonpregnant patients with cytology 
consistent with HSIL who were recruited during the 
study period, 71 ended up not being treated or were 
treated only a year later, and were classified as return 
after dropout. The overall dropout rate was 7.9% (95% 
CI: 6.1;9.7) regardless of the proposed approach.
Excluding those patients who brought in the results of 
biopsies performed before recruitment, 336 patients 
submitted to LLETZ (288 in the S&T group and 48 in 
the prior biopsy group) were considered treated. Table 
1 shows a comparison of mean time by approach (S&T 
versus prior biopsy).
Seven patients with characteristics that would include 
them in the two groups analyzed (four candidates for 
the S&T approach and three with biopsy showing HSIL) 
failed to show up for treatment (Table 2). In the two 
groups those patients who dropped out of follow-up 
after recruitment were the ones who had indication for 
an operating procedure due to an extensive lesion or had 
a treatment for colpitis. The difference in the proportion 
of dropouts in the two groups was not significant.
To evaluate overtreatment, the histological diagnosis of 
298 patients submitted to LLETZ without prior biopsy 
that matched the S&T criteria was described (Table 3). 
The proportion of negative cases was 2.0%, they were 
considered overtreatment.
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DISCUSSION
Our sample was drawn from the cervical cancer preven-
tion program in the city of Rio de Janeiro. Patients were 
submitted to oncological colpocytology in primary 
health care units.
The fact that there were cases eligible for the S&T 
approach but who were not treated during the first 
visit may explain the dropout rate and the mean time 
greater than zero between check in at the colposcopy 
unit and LLETZ.
The difference in mean time indicates that S&T is a time-
saving approach where treatment is provided 5.8-fold 
as fast as compared to the prior biopsy approach. It 
highlights major advantages of this approach: it requires 
fewer visits to the health care unit, and fewer hours of 
work missed, and potentially reduces patient anxiety. It 
also indicates greater cost savings, since a prior biopsy 
is not required. This saving should be weighted against 
the cost of overtreatment in further economic analysis 
studies. Sadan et al (2007)10 concluded that S&T 
approach may shorten the time between diagnosis and 
treatment with similar accuracy of diagnosis compared 
to the traditional protocol (prior biopsy).
The low overall proportion of dropouts is due to 
active search of patients who failed to show up at their 
appointments, and does not reflect the reality of most 
Brazilian health services. In our study there was no 
significant difference in the proportion of dropouts 
between both approaches. There might be a difference 
but it was not statistically significant at a 5% level due 
to the small sample size (beta error). The difference 
found is clinically relevant, and should it actually 
exist, it would be an important advantage in the S&T 
approach. Megevand et al (1996)6 conducted a two-
phase study in which patients in the first phase with 
abnormal cytology were referred for colposcopy and 
treatment in a hospital 20 kilometers away from the unit 
where cytology was performed. In the second phase, 
cytology, colposcopy, and treatment were performed at 
the same unit. They reported that 66% of the patients 
with cytology showing HSIL in the first phase ended 
up not undergoing colposcopy or receiving the required 
treatment, while in the second phase this rate was 1.3%. 
They concluded based on these results that the majority 
of patients with abnormal cytology would have colpos-
copy and treatment if cytological reports were more 
readily available and there were greater availability 
of colposcopy and treatment. This  could be achieved 
if diagnosis and treatment were both performed in the 
first session.
According to Denny et al (1995),2 the reduction in 
patient dropouts (without adequate treatment) is one 
of the main advantages of S&T approach and in their 
study there were no patient dropouts when S&T was 
used. Powell  (1996)8 believes that this policy could 
potentially lead to reduced costs to patients in terms 
of time and money, resulting in better compliance with 
treatment and follow-up.
The proportion of negative cases (2.0 %) seems too 
low to refrain from using the S&T approach given its 
advantages. If we add to these cases the low-grade intra-
epithelial neoplasias (CIN I and HPV infection without 
CIN – LSIL), we would have a proportion of 6.7% of 
cases which may not require treatment. However, we 
should note that these patients had cytology suggestive 
of high-grade lesion with colposcopically consistent 
lesions, in which a more aggressive diagnostic approach 
may be justified. Santos et al (1996)11 found a 2% 
overtreatment rate with biopsies performed before 
treatment, which might have removed the abnormal 
cervical area and contributed to this low proportion. 
Figure. Representation of the study population and subgroups. 
City of Rio de Janeiro, Southeastern Brazil, 1998–2004.
See-and-
treat (n= 288)
Dropouts (not treated or 
treated 1year later (n= 71): 4 
potential patients of S&T 
approach and 3 to be treated 
after prior biopsy
Cytology 
HSIL, non-
pregnant 
(n= 900)
Satisfactory 
colposcopy (n= 621)
Unsatisfactory
colposcopy  or not
reported  (n= 208)
Prior biopsy
at the
clinic (n= 48)
Other approaches
or treated based 
on prior 
biopsy (n= 285)
Table 1. Comparison of mean time between both approaches 
studied (S&T versus prior biopsy group). City of Rio de Janeiro, 
Southeastern Brazil, 1998–2004.
Approach Cases (n)
Mean time between 
capture and 
treatment (days)
SD
S&T 288 17.5 42.2 
Prior biopsy 48 102.5 81.5 
p<0.0001 (Student’s t-test)
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Luesley et al (1990)5 report a 23% rate of histology with 
coilocytosis only, which they considered an acceptable 
rate given the procedure’s low morbidity, thus justifying 
continued use of the approach. According to Denny et al 
(1995),2 biopsy prior to treatment should be considered 
in patients with low-grade cytology since 44% of the 
histopathology cases without disease were patients with 
cytology CIN I. Kattukaran et al (2002)4 consider that 
the risk of unnecessary treatment is greater in patients 
with LSIL and recommend that S&T be used exclusi-
vely in women with high-grade cytology and consistent 
colposcopic findings. Murdoch (1995)7 also considers 
that the impact of overtreatment can be managed 
with the adoption of a simple algorithm whereby 
only patients with moderate or severe dysplasias and 
compatible colposcopy have “see and treat” LLETZ. 
The major concern regarding this policy is its potential 
for overtreatment.7 We agree with these authors that the 
risk of overtreatment can be reduced with the use of 
the procedure by skilled colposcopists and by limiting 
its indication to high-grade cytology cases.
In conclusion, the S&T approach when used based on 
appropriate criteria can be highly valuable as part of a 
protocol to manage precursor lesions of cervical cancer. 
It also saves time and possibly financial resources of 
both health care services and patients. The proportion 
of unnecessary treatments was small and we find it 
acceptable in light of the advantages provided by the 
S&T approach.
Table 2. Comparison of the proportion of dropouts in both 
approaches studied (S&T versus prior biopsy group). City of 
Rio de Janeiro, Southeastern Brazil, 1998–2004.
Approach
Potential 
patients (n)
Dropouts (n) % 95% CI
S&T 292 4 1.4 0.04;2.7
Prior biopsy 51 3 5.9 0;12.3
p = 0.07 (Fisher’s exact test)
Table 3. Final histological diagnosis in 298 patients submitted 
to LLETZ without prior biopsy. City of Rio de Janeiro, 
Southeastern Brazil, 1998–2004.
Definitive diagnosis Cases (n) % 95% CI
LSILa 20 6.7 3.9;9.5
HSILb 263 88.3 84.6;91.9
Cancer (invasive or 
microinvasive)
5 1.7 0.2;3.1
Negative 6 2.0 0.4;3.6
Nonconclusive 4 1.3 0.1;2.6
Total 298 100
a Low-grade intraepithelial neoplasia (CIN I and HPV 
infection without CIN);
b High-grade intraepithelial neoplasia (CIN II or CIN III).
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